{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04937",
    "Peptide Name": "Ln65 (Synthetic AMPs, Leu-rich, Lys-rich, UCLL1; Variants: HP1, HP2, HP3, HP4, HP5, HP6, and HP7)",
    "Source": "Obtained via virtual screening and linearization of bp65",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KKLLKLLKLLL",
    "Sequence Length": 11,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": -1.11,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "64%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (81.82%) toL5K5WL: 64%; K: 36%. GRAVY: 1.Activity: active against E. coli W3110 (MIC 4 ug/ml), P. aeruginosa PAO1 (MIC 2-4 ug/ml), A. baumannii ATCC19606 (MIC 2-4 ug/ml), K. pneumoniae NCTC418 (MIC 4 ug/ml), and S. aureus COL MRSA (MIC 4 ug/ml).In vitro toxicity: incubation 4 h; minimalum hemolytic concentration (MHC): 125 ug/ml.SAR: incorporation of D-amino acids at different positions (position 2: HP1; positions 1,2: HP2; positions 2,5: HP3; positions 2,4: HP4; positions 1,11: HP5; positions 6,7: HP6; positions 1,2,11: HP7: modulated peptide activity and hemolysis.",
    "Author": "Orsi M, Personne H, Bonvin E, Paschoud T, Olcay B, Hu X, Javor S, Reymond JL. 2024",
    "Reference": "Chimia (Aarau). 2024 Oct 30;78(10):648-653. doi: 10.2533/chimia.2024.648.PubMed",
    "Title": "Chemical Space for Peptide-based Antimicrobials."
  },
  "3D Structure": []
}